Obstructive sleep apnea (OSA) may be associated with an increased risk of developing Parkinson disease, although early treatment with continuous positive airway pressure (CPAP) could help mitigate ...
Zacks Investment Research on MSN
Here's why you should retain INSP stock in your portfolio now
Inspire Medical Systems INSP is well poised for growth in the coming quarters amid a major product transition. Management ...
Inspire therapy at Ascension Sacred Heart Emerald Coast offers obstructive sleep apnea treatment without the need for a mask ...
With a career in helping Paducah residents find better sleep, one local surgeon is recognized for his work treating ...
Obstructive sleep apnea, or OSA, let’s start with the definition. It’s a sleep problem where someone has recurrent episodes ...
Obstructive sleep apnea (OSA) is a common sleep disorder in the U.S. affecting tens of millions, with estimates ranging from ...
Rachel works as a CRNA where she provides anesthesia care across the lifespan, including pediatric anesthesia, with a primary focus on orthopedic anesthesia. She is also an Assistant Professor at the ...
A class action lawsuit was filed against Inspire Medical Systems ($INSP) on November 6, 2025. Plaintiffs in the federal ...
News-Medical.Net on MSN
Study examines fairness of oxygen desaturation thresholds in sleep apnea diagnosis
Obstructive sleep apnea (OSA) is a common sleep disorder in the U.S. affecting tens of millions, with estimates ranging from 25 to more than 80 million adults.
Huxley Medical, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for central sleep apnea (CSA) detection for its SANSA home sleep apnea test.
Aetna has clarified that, while durable medical equipment (DME) providers do not use G codes for traditional Medicare fee-for-service claims, it believes G codes can be used for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results